ENVAFOLIMAB

UNII: ES1M06M6QH
Preferred Substance Name: ENVAFOLIMAB

2102192-68-5
ANTI-PD-L1 MONOCLONAL ANTIBODY KN035
ASC22
ASC-22
ENVAFOLIMAB [INN]
ENVAFOLIMAB [WHO-DD]
IMMUNOGLOBULIN G, ANTI-(HUMAN PROGRAMMED DEATH LIGAND 1) (HUMAN-CAMELIDAE MONOCLONAL KN-035 .GAMMA.-CHAIN VARIABLE REGION FRAGMENT) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN MONOCLONAL KN-035 .GAMMA.1-CHAIN FC FRAGMENT), DIMER
KN035
KN-035

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

ENVAFOLIMAB

Synonyms and Mappings

Resources

Note